OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors
Shuchan Sun, Awaguli Dawuti, Difei Gong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13015-13015
Open Access | Times Cited: 23

Showing 23 citing articles:

Pyroptosis: Mechanisms and links with diabetic cardiomyopathy
Pan Liu, Zhengdong Zhang, Huizhen Chen, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102182-102182
Closed Access | Times Cited: 12

Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy
Juan Zhen, Xia Sheng, Tianlong Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11

Puerarin Inhibits NLRP3-Caspase-1-GSDMD-Mediated Pyroptosis via P2X7 Receptor in Cardiomyocytes and Macrophages
Shuchan Sun, Difei Gong, Ruiqi Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13169-13169
Open Access | Times Cited: 18

Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease
Feng-Qing Xu, Jingshan Shi
Journal of Alzheimer s Disease (2025)
Closed Access

β-ecdysone/PLGA composite scaffolds promote skull defect healing in diabetic rat
Yicai Luo, Ziwei Wu, Yingjuan Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access

Advances of research in diabetic cardiomyopathy: diagnosis and the emerging application of sequencing
Qianqian He, Zhizhen Lai, Zidan Zhai, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access

Puerarin Reversing Autophagy‐Lysosomal Dysfunction via Acid Sphingomyelinase Inhibition in Cardiomyocytes
Yu‐Cui Li, Qian He, Xiao‐ying Yu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 4
Open Access

Non-coding RNAs modulate pyroptosis in diabetic cardiomyopathy: A comprehensive review
Wenyu Shang, Xiaofei Geng, Xitong Sun, et al.
International Journal of Biological Macromolecules (2025), pp. 142865-142865
Closed Access

Diabetes cardiomyopathy: targeted regulation of mitochondrial dysfunction and therapeutic potential of plant secondary metabolites
Xianglong Pan, Erwei Hao, Fan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Gasdermin D-Mediated Pyroptosis in Diabetic Cardiomyopathy: Molecular Mechanisms and Pharmacological Implications
Zhou Liu, Yifan Chen, Mei Yu, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7813-7813
Open Access | Times Cited: 7

Research of Mitochondrial Function, Structure, Dynamics and Intracellular Organization
Andrey Kuznetsov, Michael J. Ausserlechner
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 886-886
Open Access | Times Cited: 5

Phlorizin ameliorates myocardial fibrosis by inhibiting pyroptosis through restraining HK1-mediated NLRP3 inflammasome activation
Yuling Zhang, Xizhen Cheng, Yanan Wang, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21217-e21217
Open Access | Times Cited: 5

A Review on the Natural Products in Treatment of Diabetic Cardiomyopathy (DCM)
Pengyu Yao, Xiaoni Yang, Yun Qiao
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 1

The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis
Xiaofei Geng, Wen-Yu Shang, Zhongwen Qi, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 10, pp. 108848-108848
Closed Access | Times Cited: 1

TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
Xiaolong Zhao, Jing Zhang, Feng Xu, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1

In-Silico Screening to Identify Phytochemical Inhibitor for hP2X7: A Crucial Inflammatory Cell Death Mediator in Parkinson’s Disease
Sabiya Samim Khan, Dharmendra Kumar Khatri
Computational Biology and Chemistry (2024) Vol. 115, pp. 108285-108285
Closed Access | Times Cited: 1

Targeting the programmed cell death (PCD) signaling mechanism with natural substances for the treatment of diabetic cardiomyopathy (DCM)
Xiaoyu Xuan, Shiliang Zhang
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5495-5508
Closed Access | Times Cited: 3

Study of Therapeutic Mechanisms of Puerarin against Sepsis-Induced Myocardial Injury by Integrating Network Pharmacology, Bioinformatics Analysis, and Experimental Validation
Yin Li, Lei Feng, Lin Bai, et al.
Critical Reviews in Immunology (2023) Vol. 43, Iss. 3, pp. 25-42
Closed Access | Times Cited: 2

Rida Herbal Bitters Improve Cardiovascular Function in High-fat Diet/Streptozotocin-induced Diabetic Rats
F.O. Ajao, Balogun Damilola Ayodeji, Marcus Olaoye Iyedupe, et al.
Journal of Cardiology and Cardiovascular Medicine (2024) Vol. 9, Iss. 1, pp. 044-051
Open Access

VPO1 Promotes Programmed Necrosis of Cardiomyocytes in Rats with Chronic Heart Failure by Upregulating CYLD
Yinzhuang Zhang, Zhijie Shen, Z. Mao, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 12
Open Access

Page 1

Scroll to top